about
Copy Number Changes Are Associated with Response to Treatment with Carboplatin, Paclitaxel, and Sorafenib in MelanomaExpression of drug targets in patients treated with sorafenib, carboplatin and paclitaxelTemporally Structured Replay of Awake Hippocampal Ensemble Activity during Rapid Eye Movement SleepGCF2: expression and molecular analysis of repression.Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases.Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.MEK inhibition affects STAT3 signaling and invasion in human melanoma cell linesGermline determinants of clinical outcome of cutaneous melanoma.Concurrent MEK2 mutation and BRAF amplification confer resistance to BRAF and MEK inhibitors in melanoma.Cardiovascular function and the veteran athlete.The histone deacetylase inhibitor trichostatin A blocks progesterone receptor-mediated transactivation of the mouse mammary tumor virus promoter in vivo.Chemotherapy for Melanoma.Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer.Acute visual loss after ipilimumab treatment for metastatic melanoma.Physiological left ventricular hypertrophy or hypertrophic cardiomyopathy in an elite adolescent athlete: role of detraining in resolving the clinical dilemma.Identification and characterization of a negative regulatory element within the epidermal growth factor receptor gene first intron in hormone-dependent breast cancer cells.Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors.Primary Melanoma Histologic Subtype: Impact on Survival and Response to TherapyStudy Design, Protocol and Profile of the Maternal And Developmental Risks from Environmental and Social Stressors (MADRES) Pregnancy Cohort: a Prospective Cohort Study in Predominantly Low-Income Hispanic Women in Urban Los Angeles.Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause?Energy expenditure in the Race Across America (RAAM)Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patientsImpact of initial stage on metastatic melanoma survival
P50
Q27853202-D97694CA-EDAC-43C6-9CD1-C9B985D64009Q28535159-E95472F4-18A1-4D10-AB3F-C554C0F4F809Q29026583-9ABB4267-7016-4445-9616-21A8D3739D44Q31814858-4A8BF56D-BA5E-4906-94E8-681EF04503CFQ35916658-32466295-F059-48A8-9932-1223D6E7C2DFQ36902033-E80846FF-39A7-4665-B528-1A74EC9FB9B3Q37161421-BE16685B-A61A-4ABB-B578-8FAE65A8D5A9Q37258423-E1AD33BE-5CC0-470E-A482-32459F9EADA0Q37641646-E44A3EB6-C47B-4406-9E14-01D4706E8278Q37765827-BBE09521-95BE-413E-B570-009DFC1D6934Q38292489-CF58E986-75A3-4B66-81A7-797EA5A17380Q38646108-BCB5AB33-6F04-41FC-BC30-0979AF14BD8BQ40110096-DB3E34BC-31CC-40C5-A5AB-F15EF47E7CF7Q41485806-E2473939-8FDF-4EE3-8A24-6C7F4F3943DDQ43245912-A2B6B637-A4FB-4705-A5E9-05063B861708Q43968093-E1C1B235-65C7-4475-9276-7F5A55302DDEQ48262013-9D065E04-B707-45E7-8D62-8589280D5EB8Q52615452-D9ED065B-EABF-446D-97E1-41F17ABFFB4FQ60614626-53243376-2300-423F-BB68-461A73789220Q64981006-5DBF3265-F922-430D-B47B-08835FCEE47FQ80846852-F67FBCCD-0571-4016-82FA-86BC6F39BEF9Q84193204-180AE1F0-CC21-48FD-A6BC-292CE1686452Q90615407-C3452E48-9BEF-4E5E-BD73-DF81ABCA4165Q91542175-CF9D31D5-0EB7-4BD4-9DEF-420595D72E28
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5391-7838
@en
name
Melissa Wilson
@ast
Melissa Wilson
@en
Melissa Wilson
@es
Melissa Wilson
@nl
type
label
Melissa Wilson
@ast
Melissa Wilson
@en
Melissa Wilson
@es
Melissa Wilson
@nl
prefLabel
Melissa Wilson
@ast
Melissa Wilson
@en
Melissa Wilson
@es
Melissa Wilson
@nl
P106
P31
P496
0000-0002-5391-7838